What constraints had to be taken into account for the successful completion of this project?
The major constraint was to build a new 700 m² building (3,000 m² of floor space) between two existing workshops and to join them together. The second was to ensure this extension without interrupting the activity. For this, it was necessary to ensure intercommunications between the old spaces and the new one. This situation resulted in the creation of temporary accesses for the personnel. This project was subject to strong planning issues. Although our production is carried out during the week during normal office hours, our process requires maintenance 7/7 and 24/24 hours since we are developing drugs from living organisms. It was therefore out of the question to cut our utilities at any time. The programming of technical stoppages in perfect synergy with our organization was essential. Cap Ingelec was also able to take into account an imperative deadline since the extension had to be delivered imperatively before the end of 2016. Finally, it was important to respect the budget, of the order of 10 M€.
How do you judge the collaboration with Cap Ingelec?
Given our imperatives, we appreciated that this collaboration started quickly and efficiently. The engineering company immersed itself very quickly in the dossier and showed great reactivity. This capacity to adapt and react was accompanied by a very good understanding of the multiple parameters of a complex site where it was essential to maintain the activity at the same level of quality and safety. This efficiency was verified on all the missions entrusted to Cap Ingelec. I am thinking of the construction of the extension itself, but also of the setting up of the GMP (quality), passing through the management of effluents or the springklage of the premises for example (automatic extinction system).
What ingredients did Cap Ingelec use to carry out its missions efficiently?
First of all, the company knew how to find and bring the right skills useful to the project. Then, they put in place an organization which allowed for a very good management of the site. I include both the project manager on site who was able to lead and coordinate the various parties involved and the steering committee which made it possible to control the various aspects of the project (reporting, monitoring, etc.). Cap Ingelec’s knowledge and experience in the world of health and industrial clean rooms also played a role. Together, we sought to respect in the smallest details the European and American regulations specific to the manufacture of medicines. It is moreover planned that we will receive the FDA (Food and Drug Administration2) in the first half of 2017 in anticipation of marketing our products on the American market.